Accounting for Debt Issuance Costs

Subscribe to newsletter

Companies obtain finance from various sources. Each source comes with its costs. For debt, companies must incur expenses, such as underwriting, legal and professional, and credit rating agency fees. These expenses fall under debt issuance costs.

What are Debt Issuance Costs?

Debt issuance costs, also known as debt issuance fees or bond issuance costs, are the expenses incurred by a company when it raises funds through publishing debt securities, such as bonds or notes. These costs represent the fees associated with issuing debt instruments to investors. Debt issuance costs are considered a type of deferred financing cost and are treated as an asset or contra liability on the company’s balance sheet.

Debt issuance costs constitute a cost related to obtaining funds or, in this case, debt finance. Usually, most of these costs occur at the initial stages of the process. However, companies may also incur them during or after the debt gets issued. These costs can also contribute to more expenses in the future that constitute a part of these costs.

Subscribe to newsletter https://harbourfrontquant.beehiiv.com/subscribe Newsletter Covering Trading Strategies, Risk Management, Financial Derivatives, Career Perspectives, and More

What do Debt Issuance Costs include?

Debt issuance costs can include various expenses related to obtaining or issuing debts. Some of the primary examples of debt issuance costs include the following.

Underwriting fees

Fees paid to underwriters who help structure and sell the debt securities to investors.

Legal and professional fees

Legal and consulting fees related to the drafting of legal documents, regulatory compliance, and due diligence.

Printing and administrative costs

Costs associated with preparing and printing offering documents, prospectuses, and other necessary materials.

Credit rating agency fees

Charges for obtaining credit ratings from rating agencies to assess the creditworthiness of the issued debt.

Registration and filing fees

Fees paid to regulatory authorities for registering the debt securities and complying with relevant regulations.

Commission and brokerage fees

Fees paid to brokers and agents involved in the sale of the debt securities.

What is the accounting for Debt Issuance Costs?

The accounting for debt issuance costs requires companies to recognize them as a contra liability on the balance sheet. Previously, the treatment involved recording these costs as an asset and amortizing them over the total period for the loan. However, recent changes entail removing these costs from the total liability on the balance sheet. This treatment makes them a contra-liability account.

With the contra liability treatment, companies must still use debt issuance costs over the loan period. Any amortization realized under this process gets charged to the income statement as an interest expense. This treatment applies to all debt issuance costs with a few exceptions. Once the loan period ends, companies charge any remaining balance on the contra liability account to the income statement.

What is the journal entry for Debt Issuance Costs?

When a company issues debt, it uses the following journal entries to record the transaction.

Dr Cash or bank
Cr Debt (liability account)

For any debt issuance cost incurred during the process, companies use the following journal entry.

Dr Debt issuance costs (contra liability)
Cr Cash or bank or payable

Over time, companies amortize these costs. The journal entry for that is as follows.

Dr Interest expense
Cr Debt issuance costs (contra liability)

Conclusion

Debt issuance cost refers to any expenses incurred to issue debt. Usually, it occurs when companies obtain finance through issuable instruments, for example, bonds. Previously, accounting standards required companies to treat these costs as assets. However, recent changes entail recognizing them as a contra liability. Companies must amortize debt issuance costs over the loan period.

Subscribe to newsletter https://harbourfrontquant.beehiiv.com/subscribe Newsletter Covering Trading Strategies, Risk Management, Financial Derivatives, Career Perspectives, and More

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSBCA on why Trump's immigration policies may not mean a tighter jobs market
BCA on why Trump's immigration policies may not mean a tighter jobs market
Stay up-to-date with the latest news - click here
LATEST NEWSCould US tariffs ramp-up deflationary forces in Europe?
Could US tariffs ramp-up deflationary forces in Europe?
Stay up-to-date with the latest news - click here
LATEST NEWSDelta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 with Venetoclax
Delta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 with Venetoclax

TOKUSHIMA, Japan — Following to the previous information on Oct. 28th. in 2024, we are excited to share our latest development status. We are pleased to announce that the data review committee (DMC) has approved the tolerability of the first three patients enrolled in the…

Stay up-to-date with the latest news - click here
LATEST NEWS89bio director Charles McWherter purchases $80,000 in stock
89bio director Charles McWherter purchases $80,000 in stock
Stay up-to-date with the latest news - click here
LATEST NEWSRETRANSMISSION: HIVE Digital Technologies Announces November 2024 Production Results and Strategic Milestones
RETRANSMISSION: HIVE Digital Technologies Announces November 2024 Production Results and Strategic Milestones
Stay up-to-date with the latest news - click here

Leave a Reply